Galenica AG (GALNF) Research
Galenica AG, a Bern, Switzerland-based company founded in 1927, functions as a prominent healthcare service provider, operating across Switzerland and on an international scale. Its comprehensive operations are strategically divided into two primary segments: Products & Care, and Logistics & IT. Within the Products & Care division, Galenica manages an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner locations. These operate under established brand names such as Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy management, this segment is also responsible for delivering medication for at-home patient treatment, launching and distributing a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, and providing dedicated marketing and sales assistance to its healthcare industry collaborators. The Logistics & IT segment delivers a suite of specialized pre-wholesale services to pharmaceutical and other healthcare enterprises. These offerings encompass storage, efficient distribution, and debt collection. Furthermore, this division provides broader logistics and IT infrastructure, including a master data system specifically designed for the healthcare sector. It also focuses on developing sophisticated management solutions for the healthcare market and is responsible for publishing both digital and print technical information about pharmaceutical products, in addition to offering comprehensive management platforms for pharmacies.
Market snapshot
- Symbol
- GALNF
- Price
- $115
- Day change
- 0.00%
- Market cap
- $4.2B
- P/E ratio
- 23.17x
- 52-week range
- 75.25-116.19
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Next earnings
- in 2 months
Peer companies
Open Galenica AG (GALNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.